347-787-6824
Blog 
In addition to your RSS feed subscription, you can also sign up for the Firm’s Blog & Press Release post notification by entering your e-mail address and clicking “Subscribe” below.
After Patent Life, FDA says NO to Generic OxyContin
After Patent Life, FDA says NO to Generic OxyContin Background Under the Food, Drug, & Cosmetic (FD&C) Act and implementing regulations, the Food and Drug Administration (FDA) is responsible for ensuring that all new drugs are safe and effective. FDA also regulates the advertising and promotion of prescription drugs under the FD&C Act. Purdue Pharma L.P., based in Stamford, CT, is a privately held pharmaceutical company founded by physicians. The FDA approved Purdue Pharma’s controlled-release pain reliever OxyContin in 1995. OxyContin (oxycodone hydrochloride controlled-release) is an opioid analgesic supplied in various dosages for oral administration. OxyContin is Purdue’s brand for tim Read More
- « Previous
- 1
- 2
- 3
